Jun-Mei Zhao, Lu Zhang, Qing-Wei Du, Cai-Qin Mu, Yv-Lian Ren, Lei-Ping Hu, Ge Shen, Li-Wei Zhuang, Yao Lu, Guo-Hua Qiu, Qing-Feng Sun, Yun-Zhong Wu, Min Yang, Ming-Hui Li, Yao Xie, Jun Cheng, Dao-Zhen Xu
{"title":"[Analyse related factors of impact and prognosis of 73 cases of severe hepatitis].","authors":"Jun-Mei Zhao, Lu Zhang, Qing-Wei Du, Cai-Qin Mu, Yv-Lian Ren, Lei-Ping Hu, Ge Shen, Li-Wei Zhuang, Yao Lu, Guo-Hua Qiu, Qing-Feng Sun, Yun-Zhong Wu, Min Yang, Ming-Hui Li, Yao Xie, Jun Cheng, Dao-Zhen Xu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>A retrospective study was conducted to investigate the clinical features and prognostic factors of 73 cases of severe hepatitis.</p><p><strong>Methods: </strong>To summarize clinical features of 73 cases of severe hepatitis, grouping by etiology and pathogenesis. A retrospective analysis was performed to evaluate the relationship between biochemical characteristics (liver function, renal function, electrolytes, PTA, etc) and complications (hepatic encephalopathy, upper gastrointestinal bleeding, hepatorenal syndrome, ascites, abdominal infections, etc) and prognosis.</p><p><strong>Results: </strong>(1) HBV infection alone accounted for 65.75%. Alcoholic liver disease, drug-induced liver injury, hepatitis E, autoimmune hepatitis, overlapping causes and other factors were five cases (6.85%), six cases (8.22%), two cases (2.74%), two cases (2.74%), seven cases (9.59%) and three cases (4.11%) respectively. According to the incidence rate, severity and underlying liver condition, subacute hepatitis, cases based on chronic hepatitis and on cirrhosis were 12 cases (16.43%), 11 cases (15.07%), 50 cases (68.49%) respectively. Clinical manifestations with or without hepatic encephalopathy accounted for 58.90% or 41.10%. (2) The highest mortality of severe hepatitis was alcoholic liver disease and patients on the basis of overlapping factors (66.67%), followed by autoimmune liver disease (50%). The mortality of HBV-related hepatitis was 18.75%. Overall mortality of 73 cases of severe hepatitis was 28.77%, of which cirrhosis group was higher than non-cirrhotic group (40% vs 4.3%, P = 0.002). The difference was statistically significant. Patients without hepatic encephalopathy had lower mortality than with hepatic encephalopathy (3.33% vs 46.51%). The mortality of patients with hepatic encephalopathy Stage III and IV was 72.73%. (3) Independent samples t test filtered nine factors associated with death, namely cirrhosis, upper gastrointestinal bleeding, hepatic encephalopathy, hepatorenal syndrome, serum creatinine, total bilirubin (TBIL), direct bilirubin (DBIL), albumin (ALB) and serum sodium. The results of multivariate conditional logistic regression analysis indicated that hepatic encephalopathy, serum creatinine levels were risk factors for death, whereas ALB as a protective factor.</p><p><strong>Conclusion: </strong>Hepatic encephalopathy, serum creatinine levels were risk factors for severe hepatitis death, But ALB was protective factor. Nucleotide analogs using was the main reason why the mortality of hepatitis B was as low as 18.75%.</p>","PeriodicalId":70973,"journal":{"name":"中华实验和临床病毒学杂志","volume":"27 5","pages":"366-9"},"PeriodicalIF":0.0000,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华实验和临床病毒学杂志","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: A retrospective study was conducted to investigate the clinical features and prognostic factors of 73 cases of severe hepatitis.
Methods: To summarize clinical features of 73 cases of severe hepatitis, grouping by etiology and pathogenesis. A retrospective analysis was performed to evaluate the relationship between biochemical characteristics (liver function, renal function, electrolytes, PTA, etc) and complications (hepatic encephalopathy, upper gastrointestinal bleeding, hepatorenal syndrome, ascites, abdominal infections, etc) and prognosis.
Results: (1) HBV infection alone accounted for 65.75%. Alcoholic liver disease, drug-induced liver injury, hepatitis E, autoimmune hepatitis, overlapping causes and other factors were five cases (6.85%), six cases (8.22%), two cases (2.74%), two cases (2.74%), seven cases (9.59%) and three cases (4.11%) respectively. According to the incidence rate, severity and underlying liver condition, subacute hepatitis, cases based on chronic hepatitis and on cirrhosis were 12 cases (16.43%), 11 cases (15.07%), 50 cases (68.49%) respectively. Clinical manifestations with or without hepatic encephalopathy accounted for 58.90% or 41.10%. (2) The highest mortality of severe hepatitis was alcoholic liver disease and patients on the basis of overlapping factors (66.67%), followed by autoimmune liver disease (50%). The mortality of HBV-related hepatitis was 18.75%. Overall mortality of 73 cases of severe hepatitis was 28.77%, of which cirrhosis group was higher than non-cirrhotic group (40% vs 4.3%, P = 0.002). The difference was statistically significant. Patients without hepatic encephalopathy had lower mortality than with hepatic encephalopathy (3.33% vs 46.51%). The mortality of patients with hepatic encephalopathy Stage III and IV was 72.73%. (3) Independent samples t test filtered nine factors associated with death, namely cirrhosis, upper gastrointestinal bleeding, hepatic encephalopathy, hepatorenal syndrome, serum creatinine, total bilirubin (TBIL), direct bilirubin (DBIL), albumin (ALB) and serum sodium. The results of multivariate conditional logistic regression analysis indicated that hepatic encephalopathy, serum creatinine levels were risk factors for death, whereas ALB as a protective factor.
Conclusion: Hepatic encephalopathy, serum creatinine levels were risk factors for severe hepatitis death, But ALB was protective factor. Nucleotide analogs using was the main reason why the mortality of hepatitis B was as low as 18.75%.
目的:回顾性分析73例重型肝炎的临床特点及影响预后的因素。方法:总结73例重型肝炎的临床特点,按病因病机分型。回顾性分析生化特征(肝功能、肾功能、电解质、PTA等)与并发症(肝性脑病、上消化道出血、肝肾综合征、腹水、腹部感染等)与预后的关系。结果:(1)单纯HBV感染占65.75%。酒精性肝病5例(6.85%)、药物性肝损伤6例(8.22%)、戊型肝炎2例(2.74%)、自身免疫性肝炎2例(2.74%)、7例(9.59%)、3例(4.11%)。根据发病率、严重程度及肝脏基础情况,亚急性肝炎12例(16.43%),以慢性肝炎为基础的11例(15.07%),以肝硬化为基础的50例(68.49%)。临床表现有或无肝性脑病分别占58.90%和41.10%。(2)重度肝炎病死率最高的是酒精性肝病和基于重叠因素的患者(66.67%),其次是自身免疫性肝病(50%)。乙型肝炎相关肝炎死亡率为18.75%。73例重型肝炎患者总死亡率为28.77%,其中肝硬化组高于非肝硬化组(40% vs 4.3%, P = 0.002)。差异有统计学意义。无肝性脑病患者的死亡率低于肝性脑病患者(3.33% vs 46.51%)。肝性脑病III期和IV期病死率为72.73%。(3)独立样本t检验过滤出肝硬化、上消化道出血、肝性脑病、肝肾综合征、血清肌酐、总胆红素(TBIL)、直接胆红素(DBIL)、白蛋白(ALB)、血清钠等9个与死亡相关的因素。多因素logistic回归分析结果显示,肝性脑病、血清肌酐水平是死亡的危险因素,而白蛋白是死亡的保护因素。结论:肝性脑病、血清肌酐水平是重型肝炎死亡的危险因素,而白蛋白是保护因素。核苷酸类似物的使用是乙肝死亡率低至18.75%的主要原因。